Adversarial Drug Discovery: The ML Arms Race Unveiled

Today’s deep-dive features Prof. Anish Kapoor, whose adversarial drug discovery techniques are redefining the pace and precision of pharmaceutical R&D. Prof. Kapoor shares how machine learning systems exploit the adversarial landscape of chemical space to expose both vulnerabilities and new opportunities for therapeutic design. We discuss security implications in drug pipelines, including how bad actors could weaponize open-source ML tools, and the countermeasures being developed by top labs. The episode reflects on the academic–industry interface in Cambridge and traces how venture-backed startups are harnessing these shifting dynamics to gain edge in a global talent arms race. Our conversation offers context-rich, actionable insights for investors and entrepreneurs navigating the next generation of computational biology breakthroughs.